MediPharm Labs Corp.
LABS.TOTSXHealthcare● Active
$0.08
+$0.01(+7.14%)
Market Cap$31864800
P/E Ratio—
52W High$0.1
52W Low$0.06
MediPharm Labs Corp. (LABS.TO) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LABS.TO · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($8.27M) | ($10.69M) | ($13.08M) | ($29.98M) | ($54.80M) |
| Depreciation & Amort. | $1.66M | $2.60M | $2.52M | $2.87M | $5.63M |
| Stock-Based Comp. | $1.34M | $0.98M | $2.03M | $2.87M | $2.40M |
| Change in Working Capital | ($0.03M) | $1.65M | $3.45M | $6.25M | $21.83M |
| Net Cash from Operations | ($5.50M) | ($4.86M) | ($12.34M) | ($16.07M) | ($13.21M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.10M) | ($0.15M) | ($0.47M) | ($0.86M) | ($0.78M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | $4.62M | $0.41M | $6.87M | $5.16M | $0.04M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.19M) | ($2.25M) | ($0.94M) | $0.39M | ($2.96M) |
| Net Cash from Financing | ($0.02M) | ($1.85M) | ($0.37M) | $0.80M | $27.80M |
| Free Cash Flow | |||||
| Free Cash Flow | ($5.60M) | ($5.01M) | ($12.81M) | ($16.93M) | ($14.00M) |
| FCF Margin %(computed) | -12.42% | -11.95% | -38.75% | -76.56% | -64.47% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · M
Explore more MediPharm Labs Corp. data
About MediPharm Labs Corp. (LABS.TO) Cash Flow Statement
MediPharm Labs Corp. generated operating cash flow of ($0.01B) and free cash flow of ($0.01B) for 2025 — a FCF margin of -12.42%. Capital expenditure was ($0.00B).
Frequently asked questions
LABS.TO · 4 questionsMediPharm Labs Corp. generated free cash flow of ($0.01B) for 2025, down 11.7% year-over-year.
LABS.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10